慢性血液透析患者心血管疾病的管理

Management of Cardiovascular Diseases in Chronic Hemodialysis Patients.

作者信息

Zhang Zhen, Wang Yaqiong

机构信息

Department of Nephrology, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.

Shanghai Medical Center for Kidney Disease, Shanghai Municipal Health Commission, 200032 Shanghai, China.

出版信息

Rev Cardiovasc Med. 2023 Jun 29;24(7):185. doi: 10.31083/j.rcm2407185. eCollection 2023 Jul.

DOI:10.31083/j.rcm2407185

PMID:39077004

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11266462/

Abstract

Hemodialysis (HD) is the main treatment modality for patients with end-stage kidney disease. Cardiovascular diseases (CVD) are highly prevalent in HD patients and are the leading cause of death in this population, with the mortality from CVD approximately 20 times higher than that of the general population. Traditional and non-traditional cardiovascular risk factors accelerate progression of CVD and exacerbate the prognosis in HD patients. This review provides a brief overview of the characteristics of CVD in HD patients, and a description of advances in its management.

摘要

血液透析（HD）是终末期肾病患者的主要治疗方式。心血管疾病（CVD）在血液透析患者中极为普遍，是该人群的主要死因，其心血管疾病死亡率比普通人群高约20倍。传统和非传统心血管危险因素加速了心血管疾病的进展，并使血液透析患者的预后恶化。本文综述简要概述了血液透析患者心血管疾病的特征，并描述了其治疗进展。